Journal
PHARMACOLOGICAL RESEARCH
Volume 178, Issue -, Pages -Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2022.106150
Keywords
Obesity; Heart failure; Cholesterol; Exercise; Pharmacology; Nutraceutical
Categories
Ask authors/readers for more resources
Cardiovascular diseases are the leading cause of death in modern societies, and arterial stiffening plays a crucial role in the development of these diseases. Perivascular adipose tissue, a relatively understudied fat depot, has direct and profound effects on arterial stiffening. Identifying it as a therapeutic target to lower arterial stiffness and reduce cardiovascular disease risk has significant clinical implications.
Cardiovascular diseases (CVD) are the leading cause of mortality in modernized societies. Arterial stiffening with aging and disease is a key pathological event leading to increased CVD morbidity and mortality. Perivascular adipose tissue (PVAT) is a fat depot not widely studied yet has direct and profound effects on arterial stiffening. Identifying PVAT as a novel therapeutic target to lower arterial stiffness and thereby CVD risk has potentially important clinical ramifications. Thus, herein, we will overview the current preclinical evidence and the associated mechanisms for PVAT to promote arterial stiffness with aging and other disease conditions. We will also discuss viable translational lifestyle and pharmacological interventions for altering PVAT function that may de stiffen arteries. Last, the translational potential for PVAT as a therapeutic target to lower arterial stiffness and CVD risk for clinical populations will be discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available